| Autor: |
Berruti, Alfredo, Sperone, Paola, Perotti, Paola, Ferrero, Anna, Dogliotti, Luigi, Terzolo, Massimo |
| Zdroj: |
Adrenocortical Carcinoma; 2011, p351-368, 18p |
| Abstrakt: |
The extreme rarity of adrenocortical carcinoma (ACC) has hampered the conduction of well-designed high-powered prospective studies testing the efficacy of systemic therapy. This limitation notwithstanding, there is evidence that chemotherapy has some activity in advanced ACC. Patients considered eligible for chemotherapy are generally patients with advanced/inoperable disease progressing with mitotane treatment or patients with ACC demonstrating a rapid pattern of tumor growth. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
